Genome-wide histone acetylation underscores tumor intrinsic immune signaling induced by photothermal therapy in ovarian cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 56 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Ovarian cancerThis series is part of our curated briefing on it.
- Samples
- 56 samples: 24 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE326102_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1443363 and SRA study SRP686991. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 28 samples read as cases, 28 as controls.
How we read this: 24 replicated groups read from 56 sample titles; they account for 48 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9622961 A2780, H3K9ac IP, 1W-treated, 10min, replicate 1 A2780, H3K9ac IP, 1W-tr…
- GSM9622962 A2780, H3K9ac IP, 1W-treated, 10min, replicate 2 A2780, H3K9ac IP, 1W-tr…
- GSM9622963 A2780, H3K9ac IP, PBO control, 10min, replicate 1 A2780, H3K9ac IP, PBO c…
- GSM9622964 A2780, H3K9ac IP, PBO control, 10min, replicate 2 A2780, H3K9ac IP, PBO c…
- GSM9622965 A2780, IgG IP, 1W-treated, 10min, replicate 1 A2780, IgG IP, 1W-treat…
- GSM9622966 A2780, IgG IP, 1W-treated, 10min, replicate 2 A2780, IgG IP, 1W-treat…
- GSM9622967 A2780, IgG IP, PBO control, 10min, replicate 1 A2780, IgG IP, PBO cont…
- GSM9622968 A2780, IgG IP, PBO control, 10min, replicate 2 A2780, IgG IP, PBO cont…
- GSM9622969 Hey, H3K9ac IP, 1W-treated, 10min, replicate 1 Hey, H3K9ac IP, 1W-trea…
- GSM9622970 Hey, H3K9ac IP, 1W-treated, 10min, replicate 2 Hey, H3K9ac IP, 1W-trea…
- GSM9622971 Hey, H3K9ac IP, PBO control, 10min, replicate 1 Hey, H3K9ac IP, PBO con…
- GSM9622972 Hey, H3K9ac IP, PBO control, 10min, replicate 2 Hey, H3K9ac IP, PBO con…
- GSM9622973 Hey, IgG IP, 1W-treated, 10min, replicate 1 Hey, IgG IP, 1W-treated…
- GSM9622974 Hey, IgG IP, 1W-treated, 10min, replicate 2 Hey, IgG IP, 1W-treated…
- GSM9622975 Hey, IgG IP, PBO control, 10min, replicate 1 Hey, IgG IP, PBO contro…
- GSM9622976 Hey, IgG IP, PBO control, 10min, replicate 2 Hey, IgG IP, PBO contro…
- GSM9622977 HH23, H3K9ac IP, 1W-treated, 10min, replicate 1 HH23, H3K9ac IP, 1W-tre…
- GSM9622978 HH23, H3K9ac IP, 1W-treated, 10min, replicate 2 HH23, H3K9ac IP, 1W-tre…
- GSM9622979 HH23, H3K9ac IP, PBO control, 10min, replicate 1 HH23, H3K9ac IP, PBO co…
- GSM9622980 HH23, H3K9ac IP, PBO control, 10min, replicate 2 HH23, H3K9ac IP, PBO co…
- GSM9622981 HH23, IgG IP, 1W-treated, 10min, replicate 1 HH23, IgG IP, 1W-treate…
- GSM9622982 HH23, IgG IP, 1W-treated, 10min, replicate 2 HH23, IgG IP, 1W-treate…
- GSM9622983 HH23, IgG IP, PBO control, 10min, replicate 1 HH23, IgG IP, PBO contr…
- GSM9622984 HH23, IgG IP, PBO control, 10min, replicate 2 HH23, IgG IP, PBO contr…
- GSM9622985 Tyknu, H3K9ac IP, 1W-treated, 10min, replicate 1 Tyknu, H3K9ac IP, 1W-tr…
- GSM9622986 Tyknu, H3K9ac IP, 1W-treated, 10min, replicate 2 Tyknu, H3K9ac IP, 1W-tr…
- GSM9622987 Tyknu, H3K9ac IP, PBO control, 10min, replicate 1 Tyknu, H3K9ac IP, PBO c…
- GSM9622988 Tyknu, H3K9ac IP, PBO control, 10min, replicate 2 Tyknu, H3K9ac IP, PBO c…
- GSM9622989 Tyknu, IgG IP, 1W-treated, 10min, replicate 1 Tyknu, IgG IP, 1W-treat…
- GSM9622990 Tyknu, IgG IP, 1W-treated, 10min, replicate 2 Tyknu, IgG IP, 1W-treat…
- GSM9622991 Tyknu, IgG IP, PBO control, 10min, replicate 1 Tyknu, IgG IP, PBO cont…
- GSM9622992 Tyknu, IgG IP, PBO control, 10min, replicate 2 Tyknu, IgG IP, PBO cont…
- GSM9622993 A2780, H3K9ac IP, 1W-treated, 6hr, replicate 1 A2780, H3K9ac IP, 1W-tr…
- GSM9622994 A2780, H3K9ac IP, 1W-treated, 6hr, replicate 2 A2780, H3K9ac IP, 1W-tr…
- GSM9622995 A2780, H3K9ac IP, PBO control, 6hr, replicate 1 A2780, H3K9ac IP, PBO c…
- GSM9622996 A2780, H3K9ac IP, PBO control, 6hr, replicate 2 A2780, H3K9ac IP, PBO c…
- GSM9622997 A2780, IgG IP, 1W-treated, 6hr, replicate 1
- GSM9622998 A2780, IgG IP, PBO control, 6hr, replicate 1
- GSM9622999 Hey, H3K9ac IP, 1W-treated, 6hr, replicate 1 Hey, H3K9ac IP, 1W-trea…
- GSM9623000 Hey, H3K9ac IP, 1W-treated, 6hr, replicate 2 Hey, H3K9ac IP, 1W-trea…
+ 16 more — browse all 56 samples with per-sample file links →
- GSE57477 Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes 72 samples same disease briefing · shares intrinsic
- GSE314300 Rb CUT&RUN profiling in ovarian cancer cell lines following CDK2 inhibitor treatment 10 samples same disease briefing
- GSE135242 Hi-C identifies structural variation associated with resistance in paired patient-derived ovarian cancer models 8 samples same disease briefing
- GSE268514 Integrative genomic analysis of Korean high-grade serous ovarian cancer 161 samples same disease briefing
- GSE28330 Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents 107 samples same disease briefing
- GSE311212 Transcriptomic profiling in human ovarian cancer cell line OVCAR-3 following CDK2 inhibitor treatment 6 samples same disease briefing
- GSE154600 Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma 5 samples same disease briefing
- GSE128098 TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target 4 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.